{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Albumin, increase to G3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Albumin, increase to G4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Alkaline Phosphatase, increase to G3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Alkaline Phosphatase, increase to G4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Alanine Aminotransferase, increase to G3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Alanine Aminotransferase, increase to G4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Aspartate Aminotransferase, increase to G3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Aspartate Aminotransferase, increase to G4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Bilirubin, increase to G3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Bilirubin, increase to G4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Creatine Kinase, increase to G3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Creatine Kinase, increase to G4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Gamma Glutamyl Transferase, increase to G3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Gamma Glutamyl Transferase, increase to G4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Potassium, increase to G3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Potassium, increase to G4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Lactate Dehydrogenase, increase to G3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Lactate Dehydrogenase, increase to G4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Magnesium, increase to G3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Magnesium, increase to G4"}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"description":"Blood samples were collected at indicated time points to assess change from baseline in albumin, alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, bilirubin, creatine kinase, gamma glutamyl transferase, potassium, lactate dehydrogenase, magnesium. Worst case grade (G) increase from baseline grade was provided for all the chemistry tests that were gradable by National Cancer Institute Common Terminology Criteria (NCI CTCAE, Version 5.0, 2017). Grade 1 = Mild AE; Grade 2 = Moderate AE; Grade 3 = Severe AE; Grade 4 = Life-threatening or disabling AE. Data for any participants with worst-case grade changes (Increase to Grade 3 or Increase to Grade 4) post-baseline were presented. Baseline was defined as latest pre-dose assessment (day 1) with a non-missing value, including those from unscheduled visits.","groups":[{"description":"Participants with relapsed/refractory multiple myeloma (RRMM) were administered with 2.5 milligram per kilogram (mg/kg) belantamab mafodotin intravenous (IV) infusion over 30-60 minutes on day 1 of each 21-days cycle. Participants were treated until disease progression, intolerable toxicity, end of study or informed consent withdrawal.","id":"OG000","title":"Belantamab Mafodotin"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All treated population","reportingStatus":"POSTED","timeFrame":"Baseline (day 1) and up to 21 months","title":"Number of Participants With Worst- Case Grade Changes Post-baseline in Clinical Chemistry Parameters","type":"SECONDARY","unitOfMeasure":"Participants"}